Title Effect of Mobile Device-Supported Single-Patient Multi-crossover Trials on Treatment of Chronic Musculoskeletal Pain : A Randomized Clinical Trial Permalink

[1]  K. Kroenke,et al.  Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial , 2018, JAMA.

[2]  Richard L Kravitz,et al.  Goals of Chronic Pain Management: Do Patients and Primary Care Physicians Agree and Does it Matter? , 2017, The Clinical journal of pain.

[3]  Stuart J Pocock,et al.  The Primary Outcome Fails - What Next? , 2016, The New England journal of medicine.

[4]  R. Kravitz,et al.  Reporting quality of N-of-1 trials published between 1985 and 2013: a systematic review. , 2016, Journal of clinical epidemiology.

[5]  K. Murray,et al.  Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain. , 2016, JAMA.

[6]  C. Bylund,et al.  The Impact of Patient Participation in Health Decisions Within Medical Encounters , 2016, Medical decision making : an international journal of the Society for Medical Decision Making.

[7]  D. Amtmann,et al.  Minimally important differences for Patient Reported Outcomes Measurement Information System pain interference for individuals with back pain , 2016, Journal of pain research.

[8]  R. Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.

[9]  Jingwei Wu,et al.  Comparative Responsiveness of the PROMIS Pain Interference Short Forms, Brief Pain Inventory, PEG, and SF-36 Bodily Pain Subscale , 2016, Medical care.

[10]  M. Hotopf,et al.  Depression in patients with chronic pain attending a specialised pain treatment centre: prevalence and impact on health care costs , 2016, Pain.

[11]  R. Kravitz,et al.  The PREEMPT study - evaluating smartphone-assisted n-of-1 trials in patients with chronic pain: study protocol for a randomized controlled trial , 2015, Trials.

[12]  Julie Brown,et al.  Evaluating the psychometric properties of the CAHPS Patient-centered Medical Home survey. , 2014, Clinical therapeutics.

[13]  R. Kravitz.  Personalized Medicine Without the “Omics” , 2014, Journal of general internal medicine.

[14]  Thomas Agoritsas,et al.  How to use a subgroup analysis: users' guide to the medical literature. , 2014, JAMA.

[15]  Christopher H. Schmid,et al.  Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research. , 2013, Journal of clinical epidemiology.

[16]  S. Vanderschueren,et al.  Concerns about medication and medication adherence in patients with chronic pain recruited from general practice , 2011, Evidence-Based Nursing.

[17]  R. Kravitz,et al.  N-of-1 Trials in the Medical Literature: A Systematic Review , 2011, Medical care.

[18]  P. Langley,et al.  The impact of pain on labor force participation, absenteeism and presenteeism in the European Union , 2010, Journal of medical economics.

[19]  Daniel J Buysse,et al.  The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. , 2010, Journal of clinical epidemiology.

[20]  David M Kent,et al.  Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal , 2010, Trials.

[21]  D. Amtmann,et al.  Development of a PROMIS item bank to measure pain interference , 2010, PAIN.

[22]  R. Hays,et al.  Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items , 2009, Quality of Life Research.

[23]  S. Asch,et al.  Development and Initial Validation of the PEG, a Three-item Scale Assessing Pain Intensity and Interference , 2009, Journal of General Internal Medicine.

[24]  Richard L Kravitz,et al.  What ever happened to N-of-1 trials? Insiders' perspectives and a look to the future. , 2008, The Milbank quarterly.

[25]  C. Nikles,et al.  Long-term changes in management following n-of-1 trials of stimulants in attention-deficit/hyperactivity disorder , 2007, European Journal of Clinical Pharmacology.

[26]  C. Schmid,et al.  Lessons learned combining N-of-1 trials to assess fibromyalgia therapies. , 2006, The Journal of rheumatology.

[27]  C. Nikles,et al.  An n-of-1 Trial Service in Clinical Practice: Testing the Effectiveness of Stimulants for Attention-Deficit/Hyperactivity Disorder , 2006, Pediatrics.

[28]  Ron D Hays,et al.  Evaluating the Statistical Significance of Health-Related Quality-Of-Life Change in Individual Patients , 2005, Evaluation & the health professions.

[29]  D. Turk.  The Potential of Treatment Matching for Subgroups of Patients With Chronic Pain: Lumping Versus Splitting , 2005, The Clinical journal of pain.

[30]  Richard L Kravitz,et al.  Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. , 2004, The Milbank quarterly.

[31]  P. Marquis,et al.  Development and validation of the pain treatment satisfaction scale (ptss): a patient satisfaction questionnaire for use in patients with chronic or acute pain , 2004, Pain.

[32]  J. Ware,et al.  Applied Longitudinal Analysis , 2004 .

[33]  B. Wolfe,et al.  Validation of a single-patient drug trial methodology for personalized management of gastroesophageal reflux disease. , 2002, Journal of managed care pharmacy : JMCP.

[34]  N. Zaias,et al.  Single-Patient Drug Trial Methodology for Allergic Rhinitis , 2002, The Annals of pharmacotherapy.

[35]  O. Gureje,et al.  Persistent Pain and Well Being: a World Health Organization Study in Primary Care , 1999 .

[36]  A. Stewart,et al.  Further validation and reliability testing of the Trust in Physician Scale. The Stanford Trust Study Physicians. , 1999, Medical care.

[37]  Roman Jaeschke,et al.  Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. , 1991, The Journal of rheumatology.

[38]  D. Cook.  Randomized trials in single subjects: the N of 1 study. , 1996, Psychopharmacology bulletin.